VIP Peptide
MODERATE EVIDENCEAlso known as: Vasoactive Intestinal Peptide, Aviptadil analogue
Investigational — not approved for general use
Educational Overview
A 28-amino-acid neuropeptide with broad signalling roles, studied in pulmonary and immune research contexts.
Research Mechanism
Acts on VPAC receptors involved in smooth-muscle relaxation, vasodilation, and immune modulation.
Areas of Study
- Pulmonary research (clinical trials)
- Immune signalling
Safety Considerations
Not approved for general use. Systemic vasoactive effects are documented. Research material only.
Frequently Asked Questions
Is this approved for human use?
No. This material is supplied for laboratory research use only by qualified businesses and institutions. It is not a medicine and is not for human or veterinary consumption.
How do I get pricing?
Request a quote and our team will respond with current pricing and available sizes for your account.
Do you provide purity documentation?
Certificates of analysis are available to approved accounts. Contact our team for batch-specific documentation.
References
References pending editorial review
We publish citations only after a qualified reviewer has verified them against the primary literature. We do not list references we have not checked. (1 queued.)
Last reviewed: 2026-07-23 · Status: in_review · References verified by editorial review before publication.
Disclaimer: Educational only. Not medical advice, diagnosis, or treatment. For research and educational purposes. Consult a licensed medical professional.